Skip to content

UPDATED 17:07 EDT / MAY 17 2013

Tableau IPO Will Take DATA from Toy to Tool – Breaking Analysis

Tableau Software,  a Big Data software company that produces interactive data visualization products, has rung the bell at New York Stock Exchange and debuted under the ticker DATA.

Initially shares were priced at $23 to $26 per share, but that has been increased to $31 per share.  Tableau is offering 8.2 million shares and has raised $254.2 million at the new share price.

Plenty of people were excited for Tableau’s IPO and NYSE debut, especially since it is a step for Big Data to go mainstream, and because investors are more willing to back companies that engage in business-to business activities rather than business-to-consumer models.

Joining Kristin Feledy in this morning’s NewsDesk is Wikibon Research Contributor Jeff Kelly to give his Breaking Analysis on Tableau’s IPO and NYSE debut.

According to Kelly, since Tableau is seen more as a toy than a tool, some of the money it raised is going to be used to build the enterprise level capabilities to create more robust security, add more management controls for IT that will enhance its self-service offerings, and of course, some of the money would be used to promote its brand.

Tableau is a data virtualization company and is a very important part of Big Data and has been very successful in Data Science.  By using tableau, you’d be able to create interesting and beautiful visualization.  According to Kelly, “they’re very successful inside that data scientist community,” and it’s “the one thing that sets them apart from some of the other business developing tools,” Kelly stated.

For more of Kelly’s Breaking Analysis on Tableau’s IPO, check out the NewsDesk video below:

Send us a news tip

Send us a News Tip

  • This field is for validation purposes and should be left unchanged.

Sign in or create an account

SIGN IN

OR

New User? SIGN UP

Join us

SIGN UP

Bio

Ethics statement

Extract the signal from the noise

Get SiliconANGLE updates and analysis.

Contact us

Partner with us

Contact us

Guest inquiry